Login / Signup

The Development of a Weighted Index to Optimise Compound Libraries for High Throughput Screening.

Chatchakorn EurtivongJóhannes Reynisson
Published in: Molecular informatics (2018)
1880 known drugs were collected and analysed for their mainstream molecular descriptors: MW, log P, HA, HD, RB and PSA. The statistical distributions were fitted to Gaussian functions for each of the descriptors. This gave a mathematical tool to calculate a weighted score, or an Index, for each descriptor. Known Drug Indexes (KDIs) were derived either by summation or multiplication of the Indexes, giving one number for each molecule calculated. The KDI summation and multiplication methods give a theoretical maxima of 6 and 1 respectively. According to both methods, methysergide (5.89/0.90), amsacrine (5.89/0.89) and fluorometholone (5.88/0.88) have the scores of the most well-balanced pharmaceuticals. The KDIs are advantageous tools in identifying the most well-balanced screening compounds based on the properties of known drugs; the screening collection can be optimised to only include quality compounds, which in turn produce tractable hit and lead compounds from the screening campaign.
Keyphrases
  • prostate cancer
  • magnetic resonance
  • contrast enhanced
  • drug induced
  • magnetic resonance imaging
  • radical prostatectomy
  • computed tomography
  • single molecule
  • adverse drug